Chu Amiens Picardie - Site Sud — Amiens

Public research footprint of Chu Amiens Picardie - Site Sud, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Refractory Transformed B-cell Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia · Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Recently updated registry entries

NCT06461897 — A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… (Recruiting)
NCT03415035 — Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With… (Completed)
NCT04210115 — Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chu Amiens Picardie - Site Sud?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.